J45.30 Insurance Policy Changes

ICD-10 J45.30 is officially defined as "Mild persistent asthma, uncomplicated." code J45.30 is referenced in 5 tracked payer policy changes from Florida Blue, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code J45.30 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Florida Blue · Effective Jun 1, 2026High impact
Coding Newsletter - Asthma
This is a comprehensive coding newsletter update on asthma diagnosis and documentation requirements effective June 2026. It emphasizes the critical distinction between asthma severity (mild/moderate/severe) and current control status, requiring providers to document both to ensure accurate ICD-10-CM coding. Billing teams must enforce complete documentation including severity, persistence, exacerbation status, and status asthmaticus to support proper code assignment (J45.2-J45.52 series) and capture associated conditions like eosinophilic asthma (J82.83).
Aetna · Effective Apr 22, 2026Medium impact
Depemokimab-ulaa (Exdensur) (CPB 1098, reviewed 2026-08-10)
Aetna considers depemokimab-ulaa (Exdensur) medically necessary for asthma in members 12 years of age or older under either of two sets of criteria. The first is a member who has previously received a biologic indicated for asthma in the past 12 months and will continue maintenance asthma treatment with the requested medication. The second is severe asthma with a baseline blood eosinophil count of at least 150 cells per microliter or dependence on oral systemic corticosteroids, uncontrolled asthma shown by two or more exacerbations requiring oral or injectable corticosteroids, one or more exacerbations resulting in hospitalization or emergency care, or poor symptom control in the past 12 months, and inadequate control despite high-dose inhaled corticosteroid and an additional controller at optimized doses. Continuation is medically necessary when asthma control has improved on the medication or the daily maintenance oral corticosteroid dose has been reduced or discontinued, and the member continues maintenance asthma treatment. Aetna considers all other indications experimental, investigational, or unproven. Members cannot use the medication with another biologic or targeted synthetic drug for the same indication. The medication must be prescribed by or in consultation with an allergist/immunologist or pulmonologist. This policy covers commercial medical plans.
Aetna · Identified Oct 5, 2026Medium impact
Infrared Therapy (CPB 0604, reviewed 2026-09-09)
Aetna considers infrared coagulation medically necessary for anal dysplasia and for members with grade I, II, or III internal hemorrhoids that are painful or persistently bleeding. Low-level infrared light therapy is considered experimental, investigational, or unproven for a long list of indications, including osteoarthritis, migraines, stroke, and diabetes mellitus, and the infrared glove is unproven for Raynaud's syndrome and all other indications. CPT 46930 is covered when selection criteria are met, while CPT 97026 and HCPCS codes A4639 and E0221 are not covered for the listed indications.
Health Net · Identified Jun 20, 2026Medium impact
20-552 Earn Incentives through the Prop 56 VBP Program
Health Net's Prop 56 Value-Based Payment (VBP) program pays add-on payments to Medi-Cal providers in Fresno, Kings and Madera counties for meeting specific measures in prenatal and postpartum care, early childhood care, chronic disease management and behavioral health integration. Payments apply to services performed on or after July 1, 2019, when submitted as a clean claim or encounter within one year from the date of service with a qualifying CPT and/or ICD-10 code. Payment amounts are higher for at-risk members, for example $70 for a prenatal care visit and $105 for an at-risk prenatal care visit, and $80 for diabetes care and $120 for at-risk diabetes care.
Health Net · Identified Jun 20, 2026Medium impact
20-554 Earn Incentives through the Prop 56 VBP Program
Health Net's Prop 56 Value-Based Payment (VBP) program pays add-on payments to Medi-Cal providers in Kern, Los Angeles, Riverside, Sacramento, San Bernardino, San Diego, San Joaquin, Stanislaus and Tulare counties for meeting specific measures in prenatal and postpartum care, early childhood care, chronic disease management and behavioral health integration. Payments apply to services performed on or after July 1, 2019, when submitted as a clean claim or encounter within one year from the date of service with a qualifying CPT and/or ICD-10 code. Payment amounts are higher for at-risk members, for example $70 for a prenatal care visit and $105 for an at-risk prenatal care visit, and $80 for diabetes care and $120 for at-risk diabetes care.

Watch J45.30

Get one email when a payer policy names J45.30, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code J45.30?

There are 5 tracked policy changes affecting code J45.30, including updates from Florida Blue, Aetna, Health Net. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code J45.30?

Payers that have issued tracked updates for code J45.30 include: Florida Blue, Aetna, Health Net.

How do I get notified when code J45.30 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code J45.30. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code J45.30?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Coding Newsletter - Asthma

Depemokimab-ulaa (Exdensur) (CPB 1098, reviewed 2026-08-10)

Infrared Therapy (CPB 0604, reviewed 2026-09-09)

20-552 Earn Incentives through the Prop 56 VBP Program

20-554 Earn Incentives through the Prop 56 VBP Program

What insurance policy changes affect code J45.30?

Which payers have updated policy for code J45.30?

How do I get notified when code J45.30 policy changes?

Why do payers change policies for code J45.30?